关于低出生体重和早产的全国常规数据:对联合国会员国 (2000-2020年) 的系统数据质量评估
Yemisrach B Okwaraji1, Ellen Bradley1, Eric O Ohuma1
1Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK.
BJOG : an international journal of obstetrics and gynaecology
|November 6, 2023
概括
这项研究评估了低出生体重和早产儿的全球数据质量. 在撒哈拉以南非洲和南亚存在显著的数据缺口,突出了改善新生儿健康监测的机会.
科学领域:
- 公共卫生 公共卫生
- 医疗信息学 医疗信息学
- 新生儿健康 新生儿健康
背景情况:
- 低出生体重和早产是新生儿脆弱性的关键指标.
- 对这些结果的准确数据对于有效的公共卫生干预和资源分配至关重要.
- 现有的行政数据源需要系统的质量评估,以确保可靠性.
研究的目的:
- 在国家常规行政数据系统中,系统地评估低出生体重和早产信息的数据质量.
- 确定数据的可用性,报告和一致性方面的区域差异.
- 为改善新生儿健康倡议数据质量和利用的战略提供信息.
主要方法:
- 使用世卫组织数据质量框架进行了系统的数据质量评估.
- 分析了195个联合国成员国 (2000-2020年) 国家常规行政系统的数据,涵盖7亿多个活产婴儿.
- 关键指标包括数据可用性,报告质量以及低出生体重和早产数据的内部/外部一致性.
主要成果:
- 64%的国家有低出生体重的国家数据,40%的国家有早产数据.
- 北美,澳大利亚和欧洲的数据报告率最高,但撒哈拉以南非洲和南亚的数据报告率最低.
- 发达地区的数据质量和一致性通常很高,但在撒哈拉以南非洲和南亚发现了重大差距和不一致性.
结论:
- 撒哈拉以南非洲和南亚地区面临着重大数据挑战,但也拥有快速改善新生儿数据收集的机会.
- 利用现有的以设施为基础的电子健康系统,并纳入精确的妊娠年龄测量,可以提高数据质量.
- 过渡到个人层面的数据收集对于监测护理质量,长期结果和实现可持续发展目标的进展至关重要.
相关概念视频
Methods Of Healthcare Delivery System
3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
International Nursing Organizations II
1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
z Scores and Area Under the Curve
10.9K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
10.9K
Bias in Epidemiological Studies
306
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
306
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


